查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
诊断酵素市场规模,份额和趋势分析报告：按类型（Taq聚合酵素,MMLV RT,HIV RT）,应用（糖尿病,肿瘤学,心臟病学）,产品类型,地区,细分市场预测2022-2030
市场调查报告书
商品编码
1171027

诊断酵素市场规模,份额和趋势分析报告：按类型（Taq聚合酵素,MMLV RT,HIV RT）,应用（糖尿病,肿瘤学,心臟病学）,产品类型,地区,细分市场预测2022-2030

Diagnostic Enzymes Market Size, Share & Trends Analysis Report By Type (Taq Polymerase, MMLV RT, HIV RT), Application (Diabetes, Oncology, Cardiology), Product Type, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 129 Pages | 商品交期: 2-10个工作天内

价格

诊断酵素市场增长和趋势

根据 Grand View Research, Inc. 的一份新报告，到 2030 年，全球诊断酵素市场规模预计将达到 62.6 亿美元，预测期内的复合年增长率为 3.97%。诊断酵素市场的增长归因于对广泛应用于病理学的诊断酵素的需求不断增长。此外，病毒感染诊断技术的进步有望推动市场增长。

由于酵素活性提供的高灵敏度和精确度，诊断酵素被广泛采用。可以比临床症状和其他诊断指标更早地检测到酵素活性。生物传感器作为医学诊断、病原体检测和监测的潜在工具正变得越来越流行。生物传感器因其准确性、灵敏度、选择性和可以常规使用的快速检测策略而受到欢迎。酵素血清水平的诊断已被用作导致细胞间成分释放到血流中的细胞毒性的指标。

呼吸道病毒感染是最常见的人类疾病之一，而以COVID-19为代表的新发病毒爆发引起的疾病对公众健康构成威胁。因此，病毒病原体的检测对于阻止此类流行病的爆发和防止不必要的抗生素使用至关重要。因此，主要参与者正在采用新的诊断策略。LightMix（Roche Molecular Diagnostics, Switzerland）, AccuPower（Bioneer, Korea）, PowerChek（Kogene Biotech, Korea）, Anyplex（Seegene, Korea）, UltraFast kits（Nanobiosys, Korea）, and DiaPlexQ（SolGent, Korea）的灵敏度为99.03%，是用于 MERS-CoV RNA 检测的商用 RT-PCR 试剂盒的一部分。

越来越多的诊断酵素测试导致了关于其性能的大量论文以及越来越多的建议和指南。此外，报销渠道缺乏明确的指南和系统的卫生技术评估（HTA）。影响诊断酵素测试付款人决定的因素包括 FDA 批准、医生支持和临床指南、竞争对手覆盖政策、成本/收益分析、HTA 结果、雇主和倡导团体等。

此外，市场上的主要参与者正专注于扩展和推出可用于广泛应用的产品。例如，2022 年 3 月，Meridian Biosciences 推出了两款可用于无创液体活检的预混液。与传统的纯化核酸 qPCR 相比，这种突破性技术的推出将能够更好地分析性能水平。

诊断酵素市场报告亮点

到 2021 年，由于生物体内大量存在酵素，葡萄糖氧化酵素/葡萄糖脱氢酵素细分市场将占据主导地位。

由于癌症患病率的增加，预计肿瘤学领域在预测期内将以最快的速度增长

对研发的重视将使临床领域成为2021年利润最高的领域。

主要市场参与者的存在正在改变诊断酵素市场，主要市场参与者专注于产品发布和地域扩张以保持其市场地位。

由于製造设施的改善和目标人群的存在，预计亚太地区在预测期内增长最快。

目录

第一章 调查方法和范围

  • 市场细分
  • 调查方法
  • 信息采购
    • 购买的数据库
    • 次要信息
    • 初步调查
    • 初步调查详情
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法一：商品流动方法
      • 方法 2：使用自下而上的方法进行国别市场估算
  • 全球市场：复合年增长率计算
  • 调查假设
  • 二级信息列表
  • 主要信息列表
  • 目的
  • 缩略语表

第二章执行摘要

  • 市场概况

3 诊断酵素市场变量、趋势和范围

  • 诊断酵素市场谱系展望
    • 母公司市场展望
    • 辅助市场展望-体外诊断（IVD）市场
  • 绘製渗透率和增长前景
  • 市场动态
  • 市场驱动力分析
    • 诊断中对酵素的需求不断增加
    • 酵素在病理学中的广泛应用
    • 病毒感染诊断检测的进展
    • 对 POC 测试的需求增加
  • 市场约束因素分析
    • 基于酵素的诊断测试成本高
    • 酵素促诊断监管和报销障碍
  • SWOT分析：按因素（政法、经济、技术）
  • 波特五力分析

4 诊断酵素市场：细分分析，按类型，2018-2030

  • 诊断酵素市场：按类型的变化分析
    • Taq聚合酵素
    • MMLVRT
    • 艾滋病抗逆转录病毒
    • 热启动 Taq Pol
    • 联合国
    • 核糖核酸酵素抑製剂
    • Bst 聚合酵素（LAMP 酵素）
    • PCR 预混液
    • 冻干聚合酵素
    • T7 RNA聚合酵素
    • Cas9酵素
    • 酸性磷酸酵素
    • 谷丙转氨酵素
    • 碱性磷酸酵素
    • 淀粉酵素
    • 血管紧张素转换酵素
    • 天冬氨酸氨基转移酵素
    • 胆碱酯酵素
    • 肌酐激酵素
    • γ谷氨□转移酵素
    • 乳酸脱氢酵素
    • 肾素
    • 葡萄糖氧化酵素/葡萄糖脱氢酵素
    • 尿酵素
    • 乳酸氧化酵素
    • 过氧化辣根
    • 谷氨酸氧化酵素
    • 其他

5 诊断酵素市场：细分分析，按应用，2018-2030

  • 诊断酵素市场：应用变化分析
    • 糖尿病
    • 肿瘤学
    • 心脏病学
    • 感染
    • 肾臟科
    • 自身免疫性疾病
    • 其他

6 诊断酵素市场：细分分析，按产品类型，2018-2030

  • 诊断酵素市场：按产品类型的变化分析
    • 分子酵素
    • 临床酵素

7. 诊断酵素市场：2018-2030 年按地区细分分析

  • 诊断酵素市场：按地区划分的变化分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
  • 亚太地区
    • 日本
    • 中国
    • 印度
  • 世界其他地区
    • 巴西
    • 南非

8 诊断酵素市场：竞争分析

  • 近期发展和影响分析：按主要市场进入者
    • 安索夫矩阵
    • 重大交易及战略联盟分析
      • 市场拓展
      • 产品发布会
      • 获得
      • 伙伴关係和协作
  • 公司分类
    • 创新者
    • 市场领导者
  • 供应商情况
    • 主要经销商及渠道合作伙伴名单
    • 主要客户
    • 2021 年主要参与者的市场份额分析
  • 上市公司
    • 公司市场分析
    • 热图分析
    • 区域网络图
    • 竞争仪錶盘分析
      • 市场差异化因素
  • 民营企业
    • 主要初创企业名单
    • 热图分析
    • 区域网络图

第九章公司简介

  • Takara Bio, Inc.
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • Promega Corporation
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • Enzo Life Sciences, Inc.
    • 公司简介
    • 产品基准
  • Merck KGaA
    • 公司简介
      • Sigma-Aldrich Co., Ltd.
    • 财务绩效
    • 产品基准
    • 战略举措
  • Thermo Fisher Scientific, Inc.
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • Creative Enzymes
    • 公司简介
    • 产品基准
  • F. Hoffmann-La Roche Ltd.
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • Solis BioDyne
    • 公司简介
    • 财务绩效
    • 产品基准
  • Ampliqon A/S
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
Product Code: GVR-4-68040-003-4

Diagnostic Enzymes Market Growth & Trends:

The global diagnostic enzymes market size is expected to reach USD 6.26 billion by 2030, registering a CAGR of 3.97% during the forecast period, according to a new report by Grand View Research, Inc.Growth of the diagnostic enzymes market is attributed to rising demand for the enzymes in diagnostics with wide applications in pathology. Moreover, advancements in diagnostic techniques for viral infection are anticipated to propel the market growth.

Diagnostic enzymes are widely adopted owing to the higher sensitivity and accuracy offered by enzyme activity. The enzyme activities can be earlier than clinical signs and other diagnostic indicators. Biosensors are becoming a popular potential tool for medical diagnostics, pathogen detection, and monitoring. Biosensors have gained popularity owing to the accuracy, sensitivity, selectivity, and rapid detection strategies that can be used routinely. Diagnosis of serum levels of the enzymes has been used as an indicator of the cellular damage that results in the release of the intercellular components into the bloodstream.

Viral infections of the respiratory tract are among the most common disorders in humans, and the ones caused due to the outbreak of emerging viruses, such as COVID-19, have posed a threat to public health. Therefore, detection of the viral pathogens is vital to stop the occurrence of such epidemics and prevent the unnecessary use of antibiotics. Therefore, novel diagnostic strategies have been adopted by the key players. LightMix (Roche Molecular Diagnostics, Switzerland), AccuPower (Bioneer, Korea), PowerChek (Kogene Biotech, Korea), Anyplex (Seegene, Korea), UltraFast kits (Nanobiosys, Korea), and DiaPlexQ (SolGent, Korea) are some of the commercially available RT-PCR kits for MERS-CoV RNA detection with sensitivities as high as 99.03%.

An increase in the number of diagnostic enzyme tests has led to a boost in recommendations and guidelines with a number of publications on their performance. Moreover, reimbursement pathways lack clear guidelines and systematic Health Technology Assessment (HTA). Various factors influencing payer decisions for diagnostic enzyme tests include FDA clearance, physician support & clinical guidelines, competitor coverage policies, cost/benefit analyses, results of HTAs, and employer or advocacy group demands.

Furthermore, key players operating in the market are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in March 2022, Meridian Bioscience, Inc. launched two master mixes, which can be used in non-invasive liquid biopsy. The launch of such breakthrough technologies enables better analysis of the performance levels as compared to traditional qPCR from the purified nucleic acid.

Diagnostic Enzymes Market Report Highlights:

  • In 2021, the glucose oxidase/glucose dehydrogenase enzyme segment held a dominant share in the market owing to the presence of an abundance of enzymes in living organisms
  • The oncology segment is projected to grow at the fastest rate during the forecast period owing to the increasing prevalence of cancer among the population
  • The clinical segment is the highest revenue-generating segment in 2021 owing to the increased focus on R&D
  • The diagnostic enzyme market is witnessing change owing to the presence of key market players focusing on product launches and geographic expansion to maintain their position in the market
  • Asia Pacific is expected to witness the fastest growth during the forecast period owing to the improved manufacturing facilities and the presence of the target population

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Secondary Sources
    • 1.3.3 Primary Research
    • 1.3.4 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-wise Market Estimation Using Bottom-Up Approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
  • 1.12 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Diagnostic Enzymes Market Variables, Trends, & Scope

  • 3.1 Diagnostic Enzymes Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook - In Vitro Diagnostics (IVD) Market
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Dynamics
  • 3.4 Market Driver Analysis
    • 3.4.1 Rise in the demand for enzymes in diagnostics
    • 3.4.2 Wide applications of enzymes in pathology
    • 3.4.3 Advancements in diagnostic testing of viral infections
    • 3.4.4 Increase in the demand for Point-of-Care testing
  • 3.5 Market Restraint Analysis
    • 3.5.1 High cost of enzyme-based diagnostic tests
    • 3.5.2 Regulatory & reimbursement hurdles for enzyme diagnostics
  • 3.6 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
  • 3.7 Porter's Five Forces Analysis

Chapter 4 Diagnostic Enzymes Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1 Diagnostic Enzymes Market: Type Movement Analysis
    • 4.1.1 Taq Polymerase
      • 4.1.1.1 Taq Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.2 MMLV RT
      • 4.1.2.1 MMLV RT Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.3 HIV RT
      • 4.1.3.1 HIV RT Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.4 Hot Start Taq Pol
      • 4.1.4.1 Hot Start Taq Pol Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.5 UNG
      • 4.1.5.1 UNG Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.6 Rnase Inhibitors
      • 4.1.6.1 Rnase Inhibitors Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.7 Bst Polymerase (LAMP Enzyme)
      • 4.1.7.1 Bst Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.8 PCR Master Mix
      • 4.1.8.1 PCR Master Mix Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.9 Lyophilized Polymerase
      • 4.1.9.1 Lyophilized Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.10 T7 RNA Polymerase
      • 4.1.10.1 T7 RNA Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.11 Cas9 Enzyme
      • 4.1.11.1 Cas9 Enzyme Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.12 Acid Phosphatase
      • 4.1.12.1 Acid Phosphatase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.13 Alanine Aminotransferase
      • 4.1.13.1 Alanine Aminotransferase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.14 Alkaline Phosphatase
      • 4.1.14.1 Alkaline Phosphatase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.15 Amylase
      • 4.1.15.1 Amylase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.16 Angiotensin Converting Enzyme
      • 4.1.16.1 Angiotensin Converting Enzyme Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.17 Aspartate Aminotransferase
      • 4.1.17.1 Aspartate Aminotransferase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.18 Cholinesterase
      • 4.1.18.1 Cholinesterase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.19 Creatinine Kinase
      • 4.1.19.1 Creatinine Kinase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.20 Gamma Glutamyl Transferase
      • 4.1.20.1 Gamma Glutamyl Transferase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.21 Lactate Dehydrogenase
      • 4.1.21.1 Lactate Dehydrogenase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.22 Renin
      • 4.1.22.1 Renin Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.23 Glucose Oxidase/Glucose Dehydrogenase
      • 4.1.23.1 Glucose Oxidase/Glucose Dehydrogenase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.24 Urease
      • 4.1.24.1 Urease Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.25 Lactate Oxidase
      • 4.1.25.1 Lactate Oxidase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.26 Horseradish Peroxide
      • 4.1.26.1 Horseradish Peroxide Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.27 Glutamate Oxidase
      • 4.1.27.1 Glutamate Oxidase Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.28 Others
      • 4.1.28.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Diagnostic Enzymes Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 5.1 Diagnostic Enzymes Market: Application Movement Analysis
    • 5.1.1 Diabetes
      • 5.1.1.1 Diabetes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.2 Oncology
      • 5.1.2.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.3 Cardiology
      • 5.1.3.1 Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.4 Infectious Diseases
      • 5.1.4.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.5 Nephrology
      • 5.1.5.1 Nephrology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.6 Autoimmune Diseases
      • 5.1.6.1 Autoimmune Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.7 Others
      • 5.1.7.1 Others Market Estimates And Forecast, 2017-2030, USD Million

Chapter 6 Diagnostic Enzymes Market - Segment Analysis, By Product Type, 2018 - 2030 (USD Million)

  • 6.1 Diagnostic Enzymes Market: Product Type Movement Analysis
    • 6.1.1 Molecular Enzymes
      • 6.1.1.1 Molecular Enzymes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.1.2 Clinical Enzymes
      • 6.1.2.1 Clinical Enzymes Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Diagnostic Enzymes Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 7.1 Diagnostic Enzymes Market: Regional Movement Analysis
  • 7.2 North America
    • 7.2.1 North America Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.3.2 UK
      • 7.3.2.1 UK Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.5 Rest of World
    • 7.5.1 Rest of World Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
    • 7.5.3 South Africa
      • 7.5.3.1 South Africa Diagnostic Enzymes Market, 2018 - 2030 (USD Million)

Chapter 8 Diagnostic Enzymes Market: Competitive Analysis

  • 8.1 Recent developments and impact analysis, by key market participants
    • 8.1.1 Ansoff Matrix
    • 8.1.2 Major Deals And Strategic Alliances Analysis
      • 8.1.2.1 Market Expansion
      • 8.1.2.2 Product Launch
      • 8.1.2.3 Acquisition
      • 8.1.2.4 Partnerships and Collaborations
  • 8.2 Company Categorization
    • 8.2.1 Innovators
    • 8.2.2 Market Leaders
  • 8.3 Vendor Landscape
    • 8.3.1 List Of Key Distributors And Channel Partners
    • 8.3.2 Key Customers
    • 8.3.3 Key Company Market Share Analysis, 2021
  • 8.4 Public Companies
    • 8.4.1 Company Market Position Analysis
    • 8.4.2 Heat Map Analysis
    • 8.4.3 Regional Network Map
    • 8.4.4 Competitive Dashboard Analysis
      • 8.4.4.1 Market Differentiators
  • 8.5 Private Companies
    • 8.5.1 List Of Key Emerging Companies
    • 8.5.2 Heat Map Analysis
    • 8.5.3 Regional Network Map

Chapter 9 Company Profiles

  • 9.1 Takara Bio, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Benchmarking
    • 9.1.4 Strategic Initiatives
  • 9.2 Promega Corporation
    • 9.2.1 Company Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Benchmarking
    • 9.2.4 Strategic Initiatives
  • 9.3 Enzo Life Sciences, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Product Benchmarking
  • 9.4 Merck KGaA
    • 9.4.1 Company Overview
      • 9.4.1.1 Sigma-Aldrich Co. Llc
    • 9.4.2 Financial Performance
    • 9.4.3 Product Benchmarking
    • 9.4.4 Strategic Initiatives
  • 9.5 Thermo Fisher Scientific, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Benchmarking
    • 9.5.4 Strategic Initiatives
  • 9.6 Creative Enzymes
    • 9.6.1 Company Overview
    • 9.6.2 Product Benchmarking
  • 9.7 F. Hoffmann-La Roche Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Benchmarking
    • 9.7.4 Strategic Initiatives
  • 9.8 Solis BioDyne
    • 9.8.1 Company Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Benchmarking
  • 9.9 Ampliqon A/S
    • 9.9.1 Company Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Benchmarking
    • 9.9.4 Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global diagnostic enzymes market, by region, 2018 - 2030 (USD Million)
  • TABLE 5 Global diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 6 Global diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 7 Global diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 8 North America diagnostic enzymes market, by country, 2018 - 2030 (USD Million)
  • TABLE 9 North America diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 10 North America diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 11 North America diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 12 U.S. diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 13 U.S. diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 14 U.S. diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 15 Canada diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 16 Canada diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 17 Canada diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 18 Europe diagnostic enzymes market, 2018 - 2030 (USD Million)
  • TABLE 19 Europe diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 20 Europe diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 21 Europe diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 22 UK diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 23 UK diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 24 UK diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 25 Germany diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 26 Germany diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 27 Germany diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 28 France diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 29 France diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 30 France diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 31 Asia Pacific diagnostic enzymes market, 2018 - 2030 (USD Million)
  • TABLE 32 Asia Pacific diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 33 Asia Pacific diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 34 Asia Pacific diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 35 Japan diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 36 Japan diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 37 Japan diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 38 China diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 39 China diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 40 China diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 41 India market, by type, 2018 - 2030 (USD Million)
  • TABLE 42 India diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 43 India diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 44 Rest of Worlddiagnostic enzymes market, 2018 - 2030 (USD Million)
  • TABLE 45 Rest of Worlddiagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 46 Rest of Worlddiagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 47 Rest of Worlddiagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 48 Brazil diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 49 Brazil diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 50 Brazil diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
  • TABLE 51 South Africa diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
  • TABLE 52 South Africa diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
  • TABLE 53 South Africa diagnostic enzymes market, by application, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Diagnostic enzymes market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Data triangulation techniques
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value-chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 Diagnostic enzymes market snapshot
  • FIG. 10 Penetration and growth prospect mapping for application, 2021 (USD Million)
  • FIG. 11 Market Dynamics
  • FIG. 12 Diagnostic enzymes market driver impact
  • FIG. 13 Enzymes in the diagnosis of diseases
  • FIG. 14 Common applications of enzymes in pathology
  • FIG. 15 Diagnostic enzymes market restraint impact
  • FIG. 16 Porter's five forces analysis
  • FIG. 17 Diagnostic enzymes market: Type outlook and key takeaways
  • FIG. 18 Common diagnostic enzymes
  • FIG. 19 Taq polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 20 MMLV-RT market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 21 HIV RT market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 22 Evaluation Index of Antibody Modified Hot Start Taq DNA Polymerase
  • FIG. 23 Hot start Taq pol market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 24 UNG market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 25 RNase inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 26 Bst polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 27 PCR master mix market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 28 Lyophilized polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 29 T7 RNA polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 30 Cas9 enzyme market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 31 Acid phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 32 Alanine aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 33 Alkaline phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 34 Amylase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 35 Angiotensin-converting enzyme market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 36 Aspartate aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 37 Cholinesterase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 38 Creatinine kinase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 39 Gamma glutamyl transferase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 40 Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 41 Renin market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 42 Glucose oxidase/Glucose dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 43 Urease market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 44 Lactate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 45 Horseradish peroxide market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 46 Glutamate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 47 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 48 Diagnostic enzymes market : Application outlook and key takeaways
  • FIG. 49 Diagnostic enzymes market: Application movement analysis
  • FIG. 50 Global diabetes prevalence data and forecast (numbers in million)
  • FIG. 51 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 52 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 53 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 54 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 55 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 56 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 57 Others market estimates and forecast, 2017-2030, USD Million
  • FIG. 58 Diagnostic enzymes market : Application outlook and key takeaways
  • FIG. 59 Diagnostic enzymes market: Product type movement analysis
  • FIG. 60 Molecular enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 61 Clinical enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 62 Diagnostic Enzymes Market: Regional outlook and key takeaways
  • FIG. 63 Diagnostic enzyme market: Regional movement analysis
  • FIG. 64 North America
  • FIG. 65 North America. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 66 U.S.
  • FIG. 67 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 68 Canada
  • FIG. 69 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 70 Europe
  • FIG. 71 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 72 UK
  • FIG. 73 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 74 Germany
  • FIG. 75 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 76 France
  • FIG. 77 France market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 78 Asia Pacific
  • FIG. 79 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 80 Japan
  • FIG. 81 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 82 China
  • FIG. 83 China. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 84 India
  • FIG. 85 India. market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 86 Rest of World
  • FIG. 87 Rest of world market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 88 Brazil
  • FIG. 89 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 90 South Africa
  • FIG. 91 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 92 Ansoff Matrix
  • FIG. 93 Strategy mapping
  • FIG. 94 Company market share analysis, 2021
  • FIG. 95 Company market position analysis
  • FIG. 96 Company market position analysis
  • FIG. 97 Heat Map Analysis
  • FIG. 98 Market differentiators
  • FIG. 99 Heat Map Analysis
  • FIG. 100 Regional Network Map